CERO · Cero Therapeutics Holdings, Inc. · Exempt Offerings
$0.07
-0.02 (-25.26%)
At close · Oct 31
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year from the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$716,309
Shares
71.63M
Volume · Oct 31
7.27M
Avg daily vol (3M)
2.14M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.